The expression of ERCC1 and BRCA1 predicts prognosis of platinum-based chemotherapy in urothelial cancer

Overview of attention for article published in OncoTargets and therapy, June 2016

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 9 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

TUMOR BURDEN AS MEASURED BY CELL FREE DNA

Application WO-2018183817-A3

World Intellectual Property Organisation (WIPO)